FDA approves drug for infantile-onset Niemann-Pick type C after analysis finds longer survival
Researchers at the National Institutes of Health (NIH) and their collaborators at Beren Therapeutics, Thousand Oaks, California, have developed a treatment for infants with Niemann-Pick type C (NPC) disease, which is a rare ...
Nov 18, 2026
0
10

